Sei Investments CO Harvard Bioscience Inc Transaction History

Sei Investments CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.28 - $6.42 $245,501 - $480,524	-74,848 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$5.16 - $7.14 $107,715 - $149,047	-20,875 Reduced 21.81%	74,848 $465,000
Q4 2021 Feb 14, 2022	BUY	$6.37 - $8.18 $62,661 - $80,466	9,837 Added 11.45%	95,723 $675,000
Q3 2021 Nov 12, 2021	BUY	$6.98 - $8.47 $221,259 - $268,490	31,699 Added 58.5%	85,886 $599,000
Q2 2021 Aug 06, 2021	BUY	$5.44 - $8.4 $294,777 - $455,170	54,187 New	54,187 $451,000
Q3 2018 Nov 08, 2018	SELL	$5.0 - $6.65 $615 - $817	-123 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$4.2 - $5.95 $5,292 - $7,497	-1,260 Reduced 91.11%	123 $1,000
Q1 2018 May 11, 2018	BUY	$3.3 - $5.15 $1,686 - $2,631	511 Added 58.6%	1,383 $7,000
Q4 2017 Feb 08, 2018	BUY	$3.08 - $3.8 $421 - $520	137 Added 18.64%	872 $3,000
Q3 2017 Nov 06, 2017	BUY	$2.7 - $3.75 $1,984 - $2,756	735	735 $3,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.